USFDA completes GMP inspection at Dr. Reddy's Telangana API facility

26 May 2025 Evaluate

United States Food & Drug Administration (USFDA) has completed a GMP inspection at Dr. Reddy’s Laboratories’ API manufacturing facility (CTO-5) in Miryalaguda, Telangana, India. The inspection was conducted from May 19, 2025 to May 24, 2025. The company has been issued a Form 483 with 2 observations, which it will address within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1235.15 18.00 (1.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×